Cargando…
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators
The development of multidrug resistance (MDR) is one of the major challenges to the success of chemotherapy treatment of cancer. This phenomenon is often associated with the overexpression of the ATP-binding cassette (ABC) transporters P-gp (P-glycoprotein, ABCB1), multidrug resistance-associated pr...
Autores principales: | Dei, Silvia, Braconi, Laura, Romanelli, Maria Novella, Teodori, Elisabetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992508/ https://www.ncbi.nlm.nih.gov/pubmed/35582565 http://dx.doi.org/10.20517/cdr.2019.31 |
Ejemplares similares
-
Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells †
por: Teodori, Elisabetta, et al.
Publicado: (2020) -
Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents
por: Lee, Jaeok, et al.
Publicado: (2021) -
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators
por: Manetti, Dina, et al.
Publicado: (2023) -
New Dual P-Glycoprotein
(P-gp) and Human Carbonic
Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers
in Cancer Cells
por: Braconi, Laura, et al.
Publicado: (2022) -
Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines
por: Feinshtein, Valeria, et al.
Publicado: (2013)